Showing 561-570 of 1836 results for "".
Inside LEVEL UP: Lead Investigator Discusses Upadacitinib Study
https://practicaldermatology.com/topics/atopic-dermatitis/inside-level-lead-investigator-discusses-upadacitinib-study/26661/Inside LEVEL UP: Lead Investigator Discusses Upadacitinib StudyScientifically Speaking: Expert Filler Tips and Cases
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-expert-filler-tips-and-cases/20005/Optimal outcomes with aesthetic injectables depend on choosing the right filler and applying the proper technique. Michael Somenek, MD; Kay Durairaj, MD; Shino Bay Aguilera, DO; and Corey Hartman, MD share cases and discuss the secrets to natural-looking, impressive improvements in the lips, chin,Conversations in Acne, Part 2
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-2/19871/From isotretinoin to antibiotics—including next generation tetracyclines—the experts talk about key considerations for optimal outcomes, including the impact of diet. They also discuss management of trunk acne and strategies to reduce the risk for bacterial resistance. Host Neal Bhatia, MD leads theAnnual Meeting Highlights; Ortho Derm's New Cash Pay Model
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-annual-meeting-highlights-ortho-derm-s-new-cash-pay-model/19579/The annual meeting of the American Academy of Dermatology features updates in medical, surgical, and cosmetic dermatology. Practical Dermatology Chief medical editor Dr. Neal Bhatia highlighted the breadth of coverage at the meeting. DermTube caught up with multiple presenters who shared pearls fromUpdates from CSF 2017
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-updates-from-csf-2017/18371/Dermatologists and core cosmetic physicians shared new insights and reviewed the developments in clinical and cosmetic dermatology at the ninth annual Cosmetic Surgery Forum in Las Vegas. Matthew Zirwas, MD addressed interest in oral supplements to support skin health. Neurotoxin pioneer Nick Lowe,eRelevance Uncovers Marketing Truths, EADV Data, Primetime for Botox
https://practicaldermatology.com/series/dermwire-tv/erelevance-uncovers-marketing-truths-eadv-data-primetime-for-botox/18429/The State of Aesthetic Healthcare Marketing 2017 from eRelevance shows that nearly 60 percent of aesthetic physicians say they either don't see results from their marketing initiatives or aren't able to measure results. Data presented at the annual meeting of the European Academy of Dermatology andRhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhofade-approved-sun-leaves-acne-behind-radiesse-turns-10/18552/The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking upRisk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORCosmeceutical Science
https://practicaldermatology.com/topics/general-topics/cosmeceutical-science/19293/Patti Farris, MD discusses recent developments in cosmeceutical formulation with an emphasis on the latest research on ingredients like botanicals, growth factors, and peptides. She reviews the best evidence for cosmeceuticals and offers tips on product selection and use in a conversation with hostDermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatology